These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18216040)

  • 1. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.
    Lie Fong S; Lugtenburg PJ; Schipper I; Themmen AP; de Jong FH; Sonneveld P; Laven JS
    Hum Reprod; 2008 Mar; 23(3):674-8. PubMed ID: 18216040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
    Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
    Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure.
    Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Müllerian hormone expression in women with premature ovarian failure.
    Méduri G; Massin N; Guibourdenche J; Bachelot A; Fiori O; Kuttenn F; Misrahi M; Touraine P
    Hum Reprod; 2007 Jan; 22(1):117-23. PubMed ID: 16954410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
    Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
    Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
    Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.
    Mulders AG; Laven JS; Eijkemans MJ; de Jong FH; Themmen AP; Fauser BC
    Hum Reprod; 2004 Sep; 19(9):2036-42. PubMed ID: 15217995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Mullerian hormone (AMH): what do we still need to know?
    La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
    Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-müllerian hormone levels in women with secondary amenorrhea.
    La Marca A; Pati M; Orvieto R; Stabile G; Carducci Artenisio A; Volpe A
    Fertil Steril; 2006 May; 85(5):1547-9. PubMed ID: 16616745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-mullerian hormone as a marker of ovarian reserve.
    Tremellen KP; Kolo M; Gilmore A; Lekamge DN
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
    Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
    Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone as a marker of ovarian reserve in patients with ovarian malignancies who have undergone fertility-preserving surgery and chemotherapy.
    Iwase A; Sugita A; Hirokawa W; Goto M; Nakahara T; Bayasula ; Kajiyama H; Shibata K; Nagatomo Y; Kikkawa F
    Gynecol Endocrinol; 2013 Apr; 29(4):357-60. PubMed ID: 23305483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
    Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
    Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E
    Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study.
    Rosendahl M; Andersen CY; Ernst E; Westergaard LG; Rasmussen PE; Loft A; Andersen AN
    Hum Reprod; 2008 Nov; 23(11):2475-83. PubMed ID: 18635528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring ovarian function in young cancer survivors.
    Su HI
    Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti mullerian hormone (AMH)--is it a new reliable marker of the ovarian reserve? Its role in predicting the ovarian response in assisted reproductive technology (ART)].
    Alshiek JA; Lessing JB; Amit A; Azem F
    Harefuah; 2012 Jul; 151(7):416-20, 435. PubMed ID: 23002694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone: a new marker for ovarian function.
    Visser JA; de Jong FH; Laven JS; Themmen AP
    Reproduction; 2006 Jan; 131(1):1-9. PubMed ID: 16388003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.